Each year, Nature Biotechnology highlights companies that received sizeable early-stage funding in the previous year. Constructive Bio is using synthetic E. coli and non-canonical amino acids to encode peptides and proteins for a range of applications.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
References
Fredens, J. et al. Nature https://doi.org/10.1038/s41586-019-1192-5 (2019).
Robertson, W. E. et al. Science https://doi.org/10.1126/science.ady4368 (2025).
Bryan, M. C. et al. Green Chem. https://doi.org/10.1039/C8GC01276H (2018).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmidt, C. Editor’s pick: Constructive Bio. Nat Biotechnol (2025). https://doi.org/10.1038/s41587-025-02850-2
Published:
DOI: https://doi.org/10.1038/s41587-025-02850-2
